Cash Flow Touyun Biotech Group Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
47.00
-79.00
-272.00
-199.00
-122.00
-147.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
8.00
-29.00
15.00
-36.00
-38.00
-11.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-29.00
-49.00
-17.00
-43.00
-69.00
-62.00
Cash Flow from Investing Activities
-10.00
-3.00
-64.00
-10.00
-47.00
-32.00
Cash Flow from Financing Activities
27.00
35.00
-32.00
95.00
23.00
145.00
Net Cash Inflow / Outflow
-12.00
-16.00
-112.00
50.00
-97.00
55.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
1.00
8.00
-3.00
4.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Touyun Biotech Group Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
47.574
-57.8690825383886
104.00
182.21%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
8.997
135.744367696497
-127.00
-93.37%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-29.636
226.935430800338
-255.00
-113.06%
Cash Flow from Investing Activities
-10.805
-56.5774152038579
46.00
80.90%
Cash Flow from Financing Activities
27.321
-167.545846496197
194.00
116.31%
Net Cash Inflow / Outflow
-12.678
2.66250487512405
-14.00
-576.17%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.442
-0.149664225159722
0.00
395.33%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 40.70% vs -192.87% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-29.64
-49.98
40.70%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
